Related Experiment Videos
[Nephrotoxicity of aminoglycosides]
1Klinika Nadciśnienia Tetniczego Instytutu Kardiologii Akademii Medycznej im. K. Marcinkowskiego w Poznaniu.
Postepy Higieny I Medycyny Doswiadczalnej
|January 1, 1990
Summary
Aminoglycoside nephrotoxicity is a significant concern. This review discusses risk factors and recent views on preventing kidney damage in patients receiving aminoglycoside (AG) antibiotics.
Area of Science:
- Pharmacology
- Nephrology
- Toxicology
Context:
- Aminoglycosides (AGs) are potent antibiotics crucial for treating severe bacterial infections.
- Nephrotoxicity is a well-documented adverse effect of AG therapy, limiting their clinical utility.
- Understanding risk factors is essential for safe and effective AG use.
Purpose:
- To present current perspectives on aminoglycoside-induced nephrotoxicity.
- To identify and discuss key risk factors associated with developing kidney damage during AG treatment.
- To inform clinical practice regarding the safe administration of aminoglycosides.
Summary:
- This paper reviews recent scientific understanding of aminoglycoside (AG) nephrotoxicity.
- It details various patient-specific and treatment-related factors that increase the risk of kidney injury.
- The discussion emphasizes a proactive approach to minimize AG-related renal adverse events.
Impact:
- Improved clinical management of patients receiving aminoglycosides.
- Reduced incidence of aminoglycoside-induced kidney damage.
- Enhanced therapeutic strategies for severe bacterial infections requiring AGs.